Last reviewed · How we verify
Benzytol (CHLOROXYLENOL)
At a glance
| Generic name | CHLOROXYLENOL |
|---|---|
| Drug class | chloroxylenol |
| Target | 5-hydroxytryptamine receptor 2B |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
- Antiseptic preparation
Common side effects
Key clinical trials
- Omega-3 Supplementation vs Demodex vs Eyelid Cleanser for Pediatric Chalazia (PHASE2)
- Effectiveness of Low Level Light Therapy and Intense Pulse Light on Mite Count as Adjuntive Therapies in Demodex Blepharitis Using Artificial Intelligent Program (Ai-Demodex) (NA)
- Morphological Analysis of Meibomian Glands (NA)
- Hypochlorous Acid Disinfection Prior to Cataract Surgery (PHASE3)
- Evaluation of SUMMIT BRUSH in Treatment of Blepharitis (NA)
- Particulate Matter, Blood Pressure, and the Sympathetic Nervous System (NA)
- Impact of Preoperative Bathing on Post Caesarean Section Surgical Site Infection (NA)
- Effectiveness of Preoperative Surgical Scrubbing Using Clorhexidine Digluconate and Parachlorometaxylenol (ECP) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzytol CI brief — competitive landscape report
- Benzytol updates RSS · CI watch RSS